Icon
+91 94997 68112
Login Register

BEPREVE (nda022288)- (1.5%)

BEPOTASTINE BESILATE BAUSCH AND LOMB INC
1.5%
Yes No
2025-Jan-13 2014-Sep-08
None None
None No
BEPREVE® is a histamine H1 receptor antagonist indicated for the treatment of itching associated with allergic conjunctivitis.
3 1 3
Total Other Developers 6
Drugs with Suitability No
1.5% ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ***. *********** *** ***** ***** **** ****, ******** ****, ******* *** ***, ****** (***) ***
****** ******* ******* *************** ******* *********** *********** ******** ***, **** **. ****/****, ******* - *********, ****** - *****, ********, ******* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.